Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
---|
10/02/2007 | CA2262421C Substituted pyrrolopyrimidines and processes for their preparation |
10/02/2007 | CA2203417C Bisarylcarbinol derivatives as inhibitors of leukotriene biosynthesis |
10/02/2007 | CA2096407C Retroviral protease inhibitors |
10/02/2007 | CA2027341C Process for the preparation of 3-(l-pyroglutamyl)-l-thiazolidine-4-carboxylic acid and its derivatives |
09/27/2007 | WO2007108559A1 Agonistic antibody directed against human thrombopoietin receptor |
09/27/2007 | WO2007108557A1 Control of intracellular target molecule by ip3 receptor-binding protein |
09/27/2007 | WO2007108554A1 Peptide having anti-hypertensive activity |
09/27/2007 | WO2007108438A1 External composition for promoting of glutathione production and relevant method |
09/27/2007 | WO2007108434A1 Expression construct for digesting aggregating protein and method of inhibiting the aggregation of aggregating protein |
09/27/2007 | WO2007108272A1 Kit for cancer therapy and pharmaceutical composition for cancer therapy |
09/27/2007 | WO2007108071A1 Antistress composition and food and drink containing the same |
09/27/2007 | WO2007108042A1 Antiinflammatory agent |
09/27/2007 | WO2007107184A1 Treatment of poultry for increasing the feed conversion rate or for reducing the incidence of ascites |
09/27/2007 | US20070225359 Dimeric compounds and their use as anti-viral agents |
09/27/2007 | US20070225321 2,4-pyrimidinediamine compounds and their uses |
09/27/2007 | US20070225308 2-Amino Quinazoline Derivative |
09/27/2007 | US20070225300 HETEROARYL SUBSTITUTED 2-PYRIDINYL AND 2-PYRIMIDINYL -6,7,8,9-TETRAHYDROPYRIMIDO[1,2-a] PYRIMIDIN-4-ONE DERIVATIVES |
09/27/2007 | US20070225296 Arylalkylamine Compound and Process for Preparing the Same |
09/27/2007 | US20070225287 Substituted Arylpyrazines |
09/27/2007 | US20070225237 Methods for the prevention and/or the treatment of glutamate cytotoxicity |
09/27/2007 | US20070225236 Methods for the prevention and/or the treatment of glutamate cytotoxicity |
09/27/2007 | US20070225235 Methods for the prevention and/or the treatment of glutamate cytotoxicity |
09/27/2007 | US20070225218 Extracellular Messengers |
09/27/2007 | US20070224204 Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents |
09/27/2007 | US20070224127 Cardiovascular disorders such as myocardial infarction, post-myocardial infarction remodeling, and congestive heart failure |
09/27/2007 | US20070224119 Toxins and radionuclides coupled to IGF-1 receptor ligands for treatment of cancer |
09/27/2007 | DE60125416T2 Stabilisierte formulierungen von 6-hydroxy-3-(4-(2-(piperidin-1-yl)ethoxy)phenoxy)-2-(4-methoxyphenyl)benzo(b)thiophen und deren salze Stabilized formulations of 6-hydroxy-3- (4- (2- (piperidin-1-yl) ethoxy) phenoxy) -2- (4-methoxyphenyl) benzo (b) thiophene and their salts |
09/27/2007 | DE202007008849U1 Korkmaterial mit Rohdiamant-Partikeln Cork with rough diamond particles |
09/27/2007 | CA2647769A1 Control of intracellular target molecule by ip3 receptor-binding protein |
09/27/2007 | CA2646460A1 Treatment of poultry for reducing the feed conversion rate or for reducing the incidence of ascites |
09/27/2007 | CA2644663A1 Agonist antibody to human thrombopoietin receptor |
09/26/2007 | EP1837342A2 Sodium-channel alpha 1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus |
09/26/2007 | EP1837329A1 Novel heteroaryl derivative |
09/26/2007 | EP1837034A1 Remedy for alzheimer´s disease |
09/26/2007 | EP1837033A1 REMEDY FOR DIABETES CONTAINING Cdk5 INHIBITOR |
09/26/2007 | EP1837032A2 Magnetoresonance preparations, device for individually selecting said preparations for increasing an organism life activity in actual environmental conditions |
09/26/2007 | EP1837031A1 Compositions and methods for treating diabetes |
09/26/2007 | EP1837025A2 Method of treating cancer using kinase inhibitors |
09/26/2007 | EP1835907A1 Medicaments for the treatment or prevention of fibrotic diseases |
09/26/2007 | EP1835898A2 Methods for modulating tumor growth and metastasis |
09/26/2007 | EP1559715B1 N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-n'-(5-methyl-3-isoxazolyl)urea salt in crystalline form |
09/26/2007 | EP1490364B1 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders |
09/26/2007 | EP1418908B1 Compounds for eliminating and/or relieving anhedonia |
09/26/2007 | EP1417173B1 Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands |
09/26/2007 | EP1417055A4 Use of copper chelators to inhibit the inactivation of protein c |
09/26/2007 | EP1414825B1 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
09/26/2007 | EP1406873B1 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
09/26/2007 | EP1383750B1 Urea derivatives as integrin alpha 4 antagonists |
09/26/2007 | EP1363650B1 Composition containing pimenta extract in aquatic animal treatment methods |
09/26/2007 | EP1358181B1 Substituted pyrrolidines as ccr-3 receptor antagonists |
09/26/2007 | EP1339678B1 Ep4 receptor selective agonists in the treatment of osteoporosis |
09/26/2007 | EP1313481B1 Pharmaceutical composition comprising condensed indole compound |
09/26/2007 | EP1302461B1 Tnf-alpha production inhibitors |
09/26/2007 | EP1263726B1 N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor xa |
09/26/2007 | EP1261585B1 Substituted indole mannich bases |
09/26/2007 | EP1228367B1 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof |
09/26/2007 | EP1228046B1 Phthalazinone derivatives as pde 4 inhibitors |
09/26/2007 | EP1222255B1 Polypeptide fragments comprising c-terminal portion of helicobacter catalase |
09/26/2007 | EP0937140B1 Antibody molecules which interact specifically with the active site or cleft of a target molecule |
09/26/2007 | CN101043896A Carbohydrase inhibitors derived from fagaceous plants and use thereof |
09/26/2007 | CN101043895A Once a day formulation for phosphate binders |
09/26/2007 | CN101041669A Non nucleoside reverse transcriptase inhibitors |
09/26/2007 | CN101041626A Tetrafluorobenzyl derivatives and pharmaceutical composition containing same |
09/26/2007 | CN101041079A Novel colloid synthetic vectors for gene therapy |
09/26/2007 | CN101041042A Radix curcumae cream Zhongxue plaster for treating spontaneous sweat and night sweat |
09/26/2007 | CN101041025A Pawpaw ferns sweet wine |
09/26/2007 | CN101040998A Mint and reed root beverage for reducing fever |
09/26/2007 | CN101040976A Qinghuo Huadu beverage |
09/26/2007 | CN101040914A Chinese traditional medicine compound for treating insafficiencg of kidney-yang and hypogastric blood stasis |
09/26/2007 | CN101040879A Method for controlling the quality of pine pollen fingerprinting in the resistance-strengthening and stasis-dispersing plant medicine |
09/26/2007 | CN101040875A Physiology injection liquid of deep seawater |
09/26/2007 | CN100339376C Nitrogen-containing aromatic ring derivatives |
09/26/2007 | CN100339374C Compounds and methods for modulation of estrogen receptors |
09/26/2007 | CN100339118C Summer heat clearing toxin resolving granules and its preparation method |
09/26/2007 | CN100339098C Application of coptic toxin resolving decoction in preparation of medicine for predventing and treating tumour chemotherapy tolerance |
09/26/2007 | CN100339088C Medicine for treating child hernia and its preparation method |
09/26/2007 | CN100339079C Substituted imidazolidines, process for their preparation, and their use as a medicament or diagnostic, and medicament comprising them |
09/26/2007 | CN100339078C Solid drug for oral use |
09/26/2007 | CN100339073C Aryl sulfonamides as serotonin antagonist for treatment of obesity |
09/26/2007 | CN100339023C Embryonic egg health-care food, and its making method |
09/25/2007 | US7273924 Antibodies to the ED-B domain of fibronectin, their construction and uses |
09/25/2007 | US7273885 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
09/25/2007 | US7273875 Blocking tumor necrosis factor; antiinflammatory agents; respiratory system disorders; bronchodilator |
09/25/2007 | US7273873 Camptothecins with a modified lactone ring |
09/25/2007 | US7273872 alpha 7 receptor is the alpha -bungarotoxin sensitive receptor that influences the release of proinflammatory cytokines from macrophages |
09/25/2007 | US7273869 P-(aminomethyl)phenyl-substituted pyrazoloquinoxalines, imidazoquinoxalines, triazoloquinoxalines and benzoquinoxalines, e.g., N,N-dimethyl-1-[4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)phenyl]methanamine; serine/threonine protein kinase inhibitors for treating cancer |
09/25/2007 | US7273863 Benzophenones as inhibitors of reverse transcriptase |
09/25/2007 | US7273858 Salts |
09/25/2007 | US7273857 Fused ring compounds substituted with a 8-azabicyclo[3.2.1]octane(cyclo)alkylene group, including benzothiazolones, e.g., 3-[3-(3-Propyl-8-aza-bicyclo[3.2.1]oct-8-yl)-propyl]-3H-benzothiazol-2-one; highly selective muscarinic agonists, particularly for the M1 and/or M4 receptor subtypes |
09/25/2007 | US7273856 Antagonist of tachykinins like neurokinins and drugs |
09/25/2007 | US7273854 Recombinant adenovirus, adeno-associated virus or herpes virus (especially a replication defective virus) containing a nucleic acid of a specific sequence encoding an antisense RNA that inhibits expression of p53. |
09/25/2007 | US7273852 Synthetic C-glycolipid and its use for treating cancer, infectious diseases and autoimmune diseases |
09/25/2007 | US7273846 Selective melanin-concentrating hormone type-1 receptor agonists |
09/25/2007 | US7273744 Heparanase-like polypeptides |
09/25/2007 | US7273612 Soluble inhibitors of vascular endothelial growth factor and use thereof |
09/25/2007 | US7273611 Proteinase K resistant surface protein of neisseria meningitidis |
09/25/2007 | US7273602 Immunotherapy for humans |
09/25/2007 | CA2547947C Azole derivatives as active superoxide radical inhibitors |
09/25/2007 | CA2387502C Multiwell scanner and scanning method |
09/25/2007 | CA2376847C Complex of eletriptan and a cyclodextrin derivative |